Massivemarkets

CTKB

Cytek Biosciences, Inc. Common Stock

Nasdaq · usd

$6.12-0.20 (-3.16%)
At close · 15-minute delayed
$6.35+0.23 (+3.76%)
As of 7:53:00 PM EST on Nov 20, 2026 · After hours

Cytek Biosciences, Inc. Common Stock (CTKB) trades at $6.12 (-3.16%) as of 7:53:00 PM EST on Nov 20, 2026, +12.71% over the past month. Market cap is $800.4M, with 3.6 days to cover in short interest.

Stock performance

How Cytek Biosciences, Inc. Common Stock (CTKB) stock has performed from one day to one year, with its 52-week range.

-3.16%
-$0.20 over 1D
$6.04$6.14$6.24$6.349:30 AM11:10 AM12:50 PM2:25 PM8:00 PM$6.12
1D
-3.16%
1W
+4.79%
1M
+12.71%
YTD
+21.19%
1Y
+4.79%
52-wk range
$3.31 – $6.39

Key statistics

Today's trading snapshot for CTKB: day range, open, previous close, volume and market cap.

Day range
$5.99 – $6.39
Open
$6.31
Prev close
$6.32
Volume
1.77M
Market cap
$800.4M
Shares out
130.78M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Cytek Biosciences, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
3.85
P/B
2.49
P/FCF
—
ROE
-25.3%
ROA
-18.2%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 20, 2026

8-K filings

Material corporate events Cytek Biosciences, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 4, 2026, Cytek Biosciences, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • Bylaw amendmentSep 29, 2026

    On September 23, 2026, the board of directors of Cytek Biosciences, Inc. unanimously adopted amended and restated bylaws of the Company (as amended and restated, the “A&R Bylaws”), effective as of such adoption date. The amendments included additional information and representations for stockholder proposals and director nominees, expanded the chairperson’s authority to disregard non-compliant nominations and proposals, incorporation of the universal proxy rules, and advance-notice and disqualification procedures for special-meeting nominations.

  • Material litigationAug 24, 2026

    On August 21, 2026, the Company announced that a jury in the United States District Court for the District of Delaware returned a verdict in the patent infringement action brought by Beckman Coulter, Inc. The jury found in the Company's favor on three of the four asserted patent claims, finding noninfringement and invalidity as to each of those three claims. With respect to one claim, the jury found no literal infringement but found infringement under the doctrine of equivalents. The jury awarded past damages consisting of $20 million in lost profits and $36.11 million in royalties.

  • Valerie Barnett's position as Chief Legal Officer and Corporate Secretary of Cytek Biosciences, Inc. (the "Company") terminated on June 29, 2026.

  • On June 18, 2026, Valerie Barnett and Cytek Biosciences, Inc. (the "Company") agreed that Ms. Barnett's position as Chief Legal Officer and Corporate Secretary of the Company would terminate effective as of June 29, 2026. Ms. Barnett's separation is not due to any disagreement with the Company's operations, policies or practices.

CTKB short interest

How heavily CTKB is shorted: shares short, days to cover and average daily volume.

Days to cover
3.6
Short interest
4.11M
Avg volume
1.15M

As of · reported to FINRA twice monthly.

CTKB news

The latest news and headlines about Cytek Biosciences, Inc. Common Stock (CTKB).

Frequently asked questions

What is the Cytek Biosciences, Inc. Common Stock (CTKB) stock price today?

Cytek Biosciences, Inc. Common Stock (CTKB) is trading at $6.12 (-3.16% on the day) as of 7:53:00 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Cytek Biosciences, Inc. Common Stock?

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single…

What is the short interest in CTKB?

As of Oct 30, 2026, CTKB has 4.11M shares short and 3.6 days to cover.

What exchange is CTKB listed on?

Cytek Biosciences, Inc. Common Stock (CTKB) trades on Nasdaq in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.

Build with AI

Build an analysis of CTKB with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CTKB analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.